Aetna expands coverage of Dendreon drug; stock jumps
Reuters via Yahoo! Canada News Fri, 28 Sep 2012 12:49 PM PDT
(Reuters) - Health insurer Aetna Inc said on Friday it will pay for a greater number of patients to receive Provenge, the prostate cancer drug made by Dendreon Corp, sending Dendreon's shares up as much as 10 percent. Aetna will now provide coverage for patients with metastatic prostate cancer who have failed to respond to hormone therapy and whose disease has spread to the lungs or the brain ... |
Sex problems common with breast cancer drugs
Reuters via Yahoo! News Fri, 28 Sep 2012 12:27 PM PDT
NEW YORK (Reuters Health) - Women treated with hormone-blocking drugs to stave off breast cancer recurrences are often dissatisfied with their sex lives, a new study from Sweden has found. More than half of older women treated with so-called aromatase inhibitors said sex was almost always painful and they frequently had "insufficient lubrication," researchers reported in the journal Menopause ... |
| |
|
No comments:
Post a Comment